Kommentar
Histone Deactylase Inhibition in R-CHOP–Treated Double-Expressor Diffuse Large B-Cell Lymphoma
JAMA · 19.05.2026 · 335 (19) · 1669
DOI: 10.1001/jama.2026.4291 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA, erschienen am 19.05.2026. Verfasst von Stephen M Ansell. Beteiligte Einrichtung: Division of Hematology, Mayo Clinic, Rochester, Minnesota. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Zitieren
APA
Ansell, S. M. (2026). Histone Deactylase Inhibition in R-CHOP–Treated Double-Expressor Diffuse Large B-Cell Lymphoma. JAMA, 335(19), 1669. https://doi.org/10.1001/jama.2026.4291
Vancouver
Ansell SM. Histone Deactylase Inhibition in R-CHOP–Treated Double-Expressor Diffuse Large B-Cell Lymphoma. JAMA. 2026;335(19):1669. doi:10.1001/jama.2026.4291
BibTeX
@article{Ansell2026,
author = {Ansell, Stephen M},
title = {Histone Deactylase Inhibition in R-CHOP–Treated Double-Expressor Diffuse Large B-Cell Lymphoma},
journal = {JAMA},
year = {2026},
volume = {335},
number = {19},
pages = {1669},
doi = {10.1001/jama.2026.4291}
}
EUVIMED